About Microvisk
Microvisk is a company based in Saint Asaph (United Kingdom) founded in 2004. Microvisk has raised $16.62 million across 3 funding rounds from investors including Oxford Technology, New Hill Management and Development Bank of Wales. Microvisk operates in a competitive market with competitors including Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Perosphere, among others.
- Headquarter Saint Asaph, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Microvisk Limited
- Date of Incorporation 05 Feb, 2004
- Jurisdiction GUILDFORD, SURREY, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.62 M (USD)
in 3 rounds
-
Latest Funding Round
$9.53 M (USD), Series B
Jan 26, 2011
-
Investors
Oxford Technology
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Microvisk
Microvisk has successfully raised a total of $16.62M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $9.53 million completed in January 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Microvisk
Microvisk has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Oxford Technology, New Hill Management and Development Bank of Wales.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage micro-VC investments are focused on UK companies.
|
Locked | Locked | Locked | |
|
Limited information is provided about New Hill Management's activities.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Microvisk
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Microvisk
Investment portfolio details for Microvisk
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Microvisk
Detailed financials for Microvisk
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Microvisk Comparisons
Peer comparison for Microvisk
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Microvisk
Microvisk operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Perosphere, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Near-patient diagnostic systems for coagulation testing are developed.
|
|
| Locked | Locked | Locked |
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
|
|
| Locked | Locked | Locked |
Smart diagnostics devices for blood coagulation analysis are developed.
|
|
| Locked | Locked | Locked |
Hemostasis and fluid replacement products are provided for medical applications.
|
|
| Locked | Locked | Locked |
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
|
Detailed competitors of Microvisk
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Microvisk
Complete news archive for Microvisk
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Microvisk
Microvisk was founded in 2004 and raised its 1st funding round 6 years after it was founded.
Microvisk is headquartered in Saint Asaph, United Kingdom. It is registered at Saint Asaph, Denbighshire, United Kingdom.
Microvisk is a funded company, having raised a total of $16.62M across 3 funding rounds to date.
Microvisk was founded in 2004 and is headquartered in Saint Asaph, United Kingdom. Operations center on the medical device sector, where a handheld tool known as Coagmax is developed to assess blood clots and glucose levels. This product incorporates micro electro-mechanical systems (MEMS) integrated with disposable smart chips for point-of-care diagnostics. Focus remains on advancing portable health monitoring technologies.
Microvisk's top competitors include Accriva Diagnostics, Diagnostica Stago and Enzyre.
Microvisk has 6 investors. Key investors include Oxford Technology, New Hill Management, Development Bank of Wales, Porton Group, and UKI2S.